| Typicality: | 0.325 |
| Saliency: | 0.177 |
| according to the drug regulator | 2 | other |
| by 84.5% | 2 | other |
| among women | 2 | transitive-object |
| vaccine → reduce → the risk of cervical cancer | 5 |
| vaccine → reduce → cervical cancer rates | 3 |
| vaccine → reduce → the risk of cervical pre-cancer | 3 |
| negative | neutral | positive |
| 0.110 | 0.598 | 0.292 |
| Raw frequency | 11 |
| Normalized frequency | 0.177 |
| Modifier score | 0.500 |
| Perplexity | 27.619 |